A drug in use clinically to help make vaccines more effective may be a powerful new tool for fighting antibiotic-resistant infections.
After successfully leading Vanderbilt-Ingram Cancer Center (VICC) through years of growth in patient volumes and enhanced care options, Michael Neuss, MD, Chief Medical Officer of the VICC Clinical Enterprise, is retiring as CMO. Neuss will be succeeded by Madan Jagasia, MBBS, MSCI, MMHC, who has been named to the George and Beverly Rawlings Directorship and is section chief, Hematology and Stem Cell Transplant and director of the Outpatient Stem Cell Clinic.
Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.
Vanderbilt scientists have discovered that a certain enzyme plays a crucial role in preventing obesity-related cardiac dysfunction.
Former NFL quarterback and two-time Pro Bowler Marc Bulger recently visited with patients and families at Monroe Carell Jr. Children’s Hospital at Vanderbilt.
The pedestrian bridge and walkway at 21st Avenue South and Edgehill Avenue will undergo routine maintenance this summer.
Accessibility Tools